Oscar Health, Inc. (NYSE:OSCR) Q4 2024 Earnings Conference Call February 4, 2025 5:00 PM ET
Company Participants
Chris Potochar – Vice President of Treasury and Investor Relations
Mark Bertolini – Chief Executive Officer
Scott Blackley – Chief Financial Officer
Conference Call Participants
Stephen Baxter – Wells Fargo
Josh Raskin – Nephron Research
Michael Ha – Baird
Jonathan Yong – UBS
Jessica Tassan – Piper Sandler
Adam Ron – Bank of America
Operator
Good evening. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health’s Fourth Quarter and Full Year 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.
I will now turn the conference over to Chris Potochar, Vice President of Treasury and Investor Relations.
Chris Potochar
Good evening, everyone. Thank you for joining us for our fourth quarter and full year 2024 earnings call. Mark Bertolini, Oscar’s Chief Executive Officer; and Scott Blackley, Oscar’s Chief Financial Officer, will host this morning’s call. This call can also be accessed through our Investor Relations website at ir.hioscar.com. Full details of our results and additional management commentary are available in our earnings release, which can be found on our Investor Relations website at ir.hioscar.com.
Any remarks that Oscar makes about the future constitute forward-looking statements within the meaning of Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors, including those discussed in our quarterly report on Form 10-Q for the period ended September 30, 2024, filed with the Securities and Exchange Commission and other filings with the SEC, including our
#Oscar #Health #OSCR #Earnings #Call #Transcript